Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: Proof of principle using dogs with spontaneously occurring tumors as a model

Clinical Cancer Research

Volumn 5, Issue 9, 1999, Pages 2653-2659

  Hershey, A Elizabeth ^a   Kurzman, Ilene D ^a   Forrest, Lisa J ^a   Bohling, Cheryl A ^a   Stonerook, Michael ^c   Placke, Michael E ^c   Imondi, Anthony R ^c   Vail, David M ^a,b,d  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c BATTELLE MEMORIAL INSTITUTE   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; PACLITAXEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; INHALATIONAL DRUG ADMINISTRATION; LUNG CARCINOMA; LUNG FIBROSIS; LUNG METASTASIS; LUNG SARCOMA; MALE; MELANOMA; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DISEASE MODELS, ANIMAL; DOG DISEASES; DOGS; DOXORUBICIN; FEMALE; LUNG NEOPLASMS; MALE; MELANOMA; PACLITAXEL; SARCOMA;

EID: 0032853556     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Smith, S. J., and Bernstein, J. A. Therapeutic uses of lung aerosols. Lung Biol. Health Dis., 94: 233-269, 1996.
2. Lipworth, B. J. Pharmacokinetics of inhaled drugs. Br. J. Clin. Pharmacol., 42: 697-705, 1996.
3. Melillo, E. M., and Balzano, G. Drugs by inhalatory route: an overview and upcoming clinical perspectives. Monaldi Arch. Chest Dis., 51: 405-412, 1996.
4. Fiel, S. B. Aerosol delivery of antibiotics to the lower airways of patients with cystic fibrosis. Chest, 107 (Suppl.): 61S-64S, 1995.
5. Chua, H. L., Collis, G. G., and Le Souef, P. N. Bronchial response to nebulized antibiotics in children with cystic fibrosis. Eur. Respir. J., 3: 1114-1116, 1990.
6. Harris, C. E., and Wilmott, R. W. Inhalation-based therapies in the treatment of cystic fibrosis. Curr. Opin. Pediatr., 6: 234-238, 1994.
7. Coleman, D. M., Kelly, H. W., and McWilliams, B. C. Therapeutic aerosol delivery during mechanical ventilation. Pulmonary and Allergy, 30: 644-655, 1996.
8. Le Conte, P., Potel, G., Peltier, P., Horeau, D., Caillon, J., Juvin, M-E., Kergueris, M-F., Bugnon, D., and Baron, D. Lung distribution and pharmacokinetics of aerosolized tabramycin. Am. Rev. Respir. Dis., 147: 1279-1282, 1993.
9. Mukhopadhyay, S., Staddon, G. E., Eastman, C. Palmer, M. Davies, E. R., and Carswell, F. The quantitative distribution of nebulized anti-biotic in the lung in cystic fibrosis. Respir. Med., 88: 203-211, 1994.
10. Smaldone, G. C., Dickinson, G., Marcial, E., Young, E., and Seymour, J. Deposition of aerosolized pentamidine and failure of pneumocystis prophylaxis. Chest, 101: 82-87, 1992.
11. Newman, S. P., and Simonds, A. K. Aerosol therapy in AIDS. Lung, 168 (Suppl.): 685-691, 1990.
12. Simonds, A. K., Newman, S. P., Johnson, M. A., Talaee, N., Lee, C. A., and Clarke, S. W. Alveolar targeting of aerosol pentamidine: toward a rational delivery system. Am. Rev. Respir. Dis., 141: 827-829, 1990.
13. Knight, V., McClung, H. V., and Wilson S. Z. Ribavirin small particle aerosol treatment of influenza. Lancet, ii: 945, 1981.
14. Wood, M. J., and Geddes, A. M. Antiviral therapy. Lancet, ii: 1189-1193, 1988.
15. Anonymous. Ribavirin and respiratory syncytial viruses. Lancet, I: 362-363, 1986.
16. Knight, V., and Gilbert, B. E. Aerosol treatment of respiratory viral disease. Lung, 168 (Suppl.): 406-413, 1990.
17. O'Riordan, T. G., Duncan, S. R., Burckhart, G. J., Griffith, B. P., and Smaldone, G. C. Production of an aerosol of cyclosporine as a prelude to clinical studies. J. Aerosol Med., 5: 171-177, 1992.
18. Dowling, R. D., Zenati, M., Burckhart G. J., Yousman S. A., Schaper, M., Simmons R. L., et al. Aerosolized cyclosporine as a single agent immunotherapy in canine lung allografts. Surgery, 108: 198-205, 1990.
19. Johnston, M. R., Minchen, R. F., and Dawson, C. A. Lung perfusion with chemotherapy in patients with unresectable metastatic sarcoma to the lung or diffuse bronchioloalveolar carcinoma. J. Thorac. Cardiovasc. Surg., 110: 368-373, 1995.
20. Tatsumura, T., Koyama, S., Tsujimoto, M., Kitagawa, M., and Kagamimori, S. Further study of nebulisation chemotherapy, a new chemotherapeutic method in the treatment of lung carcinomas: fundamental and clinical. Br. J. Cancer, 68: 1146-1149, 1993.
21. Huland, E., Huland, H., and Heinzer, H. Interleukin-2 by inhalation: local therapy for metastatic renal cell carcinoma. J. Urol., 147: 344-348, 1992.
22. Khanna, C., Hasz, D. E., Klausner, J. S., and Anderson, P. M. Aerosol delivery of interleukin-2 liposomes is nontoxic and biologically effective: canine studies. Clin Cancer Res., 2: 721-234, 1996.
23. Khanna, C., Anderson, P. M., Hasz, D. E., Katsanis, E., Neville, M., and Klausner, J. S. Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases. Am. Cancer Society, 79: 1409-1420, 1997.
24. Ogilvie, G. K., Obradovich, J. E., Elmslie, R. E., Vail, D. M., Moore, A. S., Curtis, C. R., Straw, R. C., Dickinson, K., Cooper, M. F., Withrow, S. J. Toxicoses associated with administration of mitox-antrone to dogs with malignant tumors. J. Am. Vet. Med. Assoc., 198: 1613-1617, 1991.
25. Ogilvie, G. K. Specific drugs used in veterinary chemotherapy. In: G. K. Ogilvie and A. S. Moore (eds.), Managing the Veterinary Cancer Patient, pp. 72-80. Trenton: Veterinary Learning Systems Co., 1995.
26. Johnston, M. R. Lung perfusion and other methods of targeting therapy to lung tumors. Chest Surg. Clin. North Am., 5: 139-156, 1995.
27. Ogilvie, G. K., Straw, R. C., and Jameson, V. J. Evaluation of single-agent chemotherapy for treatment of clinically evident osteosarcoma metastases in dogs: 45 cases (1987-1991). J. Am. Vet. Med. Assoc., 202: 304-306, 1993.
28. 14C-DOX) in dogs. Proc. Am. Assoc. Cancer Res., 40: 416, 1999.